Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994
Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994
Balo Concentric Sclerosis:MR Diagnosis
AJNR 15:1284-1285, Korte,J.H.,et al, 1994
Dementia in 2 Histologically Confirmed Cases of MS:One Isolated Dementia & One Assoc with Psychiatric Symptoms
JNNP 57:353-359, Fontaine,B.,et al, 1994
The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994
Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994
Clin & Path Features of an Autosomal Dominant, Adult-Onset Leukodystrophy Simul Chronic Progressive MS
Arch Neurol 51:757-766, Schwankhaus,J.D.,et al, 1994
Serial Neurologic Examinations After Near Drowning and Outcome
Arch Pediatr Adolesc Med 148:167-170, Bratton,S.L.,et al, 1994
Megadose Corticosteroids in Multiple Sclerosis
Neurol 44:1-4, Kupersmith,M.J.,et al, 1994
A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994
Chronic Spinal Cord Injury
NEJM 330:550-556, Ditunno,J.F.&Formal,C.S., 1994
Value of Magnetic Resonance Imaging-Based Measurements of Hippocampal Formations in Patients with Partial Epilepsy
Arch Neurol 51:130-138, Adam,C.,et al, 1994
The British Isles Survey of Multiple Sclerosis in Twins
Neurol 44:11-15, Mumford,C.J.,et al, 1994
Magnetic Resonance Evaluation of Disease Activity During Pregnancy in Multiple Sclerosis
Neurol 44:327-329, vanWalderveen,M.A.A.,et al, 1994
Concentric Sclerosis (Balo) :Morphometric and In Situ Hybridization Study of Lesions in Six Patients
Ann Neurol 35:18-30, Yao,D-L.,et al, 1994
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994
Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994
Treatment of Multiple Sclerosis
Lancet 343:275-279, Ebers,G.C., 1994
4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety
Arch Neurol 51:292-296, Polman,C.H.,et al, 1994
A Genetic Marker and Family History Study of the Upstate New York Multiple Sclerosis Cluster
Neurol 44:329-333, Schiffer,R.B.,et al, 1994
The Value of Diagnostic Information to Patients with Suspected Multiple Sclerosis
Arch Neurol 51:67-72, Mushlin,A.I.,et al, 1994
Effect of Diagnostic Testing for Multiple Sclerosis on Patient Health Perceptions
Arch Neurol 51:46-51, O'Connor,P.,et al, 1994
Pathogenesis of Multiple Sclerosis
Lancet 343:271-275, Ffrench-Constant,C., 1994
Takayasu Arteritis
Ann Int Med 120:919-929, Kerr,G.S.,et al, 1994
Movement Disorders Following Lesions of the Thalamus or Subthalamic Region
Mov Disord 9:493-507, Lee,M.S. &Marsden, C.D., 1994
Magnetic Resonance Imaging in Childhood Intractable Partial Epilepsies:Pathologic Correlations
Neurol 43:681-687, Kuzniecky,R.,et al, 1993
Detection of Hippocampal Pathology in Intractable Partial Epilepsy
Neurol 43:1793-1799, Jackson,G.D.,et al, 1993
Congruous Quadrantanopia and Optic Radiation Lesion
Neurol 43:1430-1432, Borruat,F.X.,et al, 1993
Measurement of Whole Temporal Lobe and Hippocampus for MR Volumetry:Normative Data
Neurol 43:2006-2010, Bhatia,S.,et al, 1993
Oral Megadose Methylprednisolone Therapy in a Pt with Chronic Progressive MS
Neurol 43:230, Gucuyener,K.,et al, 1993
Large Focal Tumor-Like Demyelinating Lesions of the Brain:Intermed Entity Between MS & Acute Dissem Encephalomyelitis?
Ann Neurol 33:18-27, Kepes,J.J., 1993
Information Processing Efficiency in Chronic Fatigue Syndromes and Multiple Sclerosis
Arch Neurol 50:301-304, DeLuca,J.,et al, 1993
Measuring Physical Impairment and Disability with the Chedoke-McMaster Stroke Assessment
Stroke 24:58-63, Gowland,C.,et al, 1993
Recovery of Functional Status After Stroke, A Postrehabilitation Follow-up Study
Stroke 24:200-250, Ferrucci,L.,et al, 1993
A Population-Based Study of Multiple Sclerosis in Twins:Update
Ann Neurol 33:281-285, Sadovnick,A.D.,et al, 1993
Magnetic Resonance Imaging of Spinal Cord in MS by Fluid-Attenuated Inversion Recovery
Lancet 341:593-594, Thomas,d.J.,et al, 1993
Survival of Profoundly Disabled People with Severe Mental Retardation
Am J Dis Child 147:329-336, Eyman,R.K.,et al, 1993
Collosal Disconnection in Multiple Sclerosis
Neurol 43:1243-1245, Schnider,A.,et al, 1993
Genetic Susceptibility in Familial Multiple Sclerosis not Linked to the Myelin Basic Protein Gene
Lancet 341:1179-1181, Rose,J.,et al, 1993
Psychological Stress as Risk Factor for Exacerbations in Multiple Sclerosis
Neurol 43:1311-1312, Nisipeanu,P.&Korczyn,A.D., 1993
Anatomic-Radiologic Basis of Lhermitte's Sign in Multiple Sclerosis
Arch Neurol 50:849-851, Gutrecht,J.A.,et al, 1993
Devic's Neuromyelitis Optica:A Clinicopathological Study of 8 Patients
Ann Neurol 34:162-168, Mandler,R.N.,et al, 1993
Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993
Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993
Plasmapheresis in Acute Episodes of Fulminant CNS Inflammatory Demyelination
Neurol 43:1100-1104, Rodriquez,M.,et al, 1993
Long-Term Safety of Azathioprine Therapy in Multiple Sclerosis
Neurol 43:831-833, Amato,M.P.,et al, 1993
Intermittent Cyclophosphamide Pulse Therapy in Progressive MS:NE Coop MS Trtm Grp
Neurol 43:910-918, Weiner,H.L.,et al, 1993
Systemic Histiocytosis Presenting as Multiple Sclerosis
Ann Neurol 33:549-554, Smith,M.E.,et al, 1993
Electrographic Seizures in Preterm & Full-Term Neonates:Clin Corr Brain Lesions, Risk for Sequelae
Pediatrics 91:128-134, Scher,M.S.,et al, 1993